Compile Data Set for Download or QSAR
Report error Found 231 Enz. Inhib. hit(s) with all data for entry = 7244
TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183589(US9145354, 241)
Affinity DataIC50: 36nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183547(US9145354, 182)
Affinity DataIC50: 38nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183530(US9145354, 157)
Affinity DataIC50: 45nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183490(US9145354, 97)
Affinity DataIC50: 47nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183527(US9145354, 152)
Affinity DataIC50: 51nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183469(US9145354, 69)
Affinity DataIC50: 52nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183540(US9145354, 171)
Affinity DataIC50: 56nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183480(US9145354, 84)
Affinity DataIC50: 57nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183434(US9145354, 32)
Affinity DataIC50: 58nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183481(US9145354, 85)
Affinity DataIC50: 61nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183545(US9145354, 179)
Affinity DataIC50: 63nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183631(US9145354, 298)
Affinity DataIC50: 64nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183636(US9145354, 303)
Affinity DataIC50: 65nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60671(US9145354, 92 | BDBM183487)
Affinity DataIC50: 66nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183526(US9145354, 150)
Affinity DataIC50: 68nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183497(US9145354, 108)
Affinity DataIC50: 70nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60669(US9145354, 24)
Affinity DataIC50: 75nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183413(US9145354, 9)
Affinity DataIC50: 76nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183493(US9145354, 103)
Affinity DataIC50: 77nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183562(US9145354, 200)
Affinity DataIC50: 78nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183577(US9145354, 224)
Affinity DataIC50: 81nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60704(US9145354, 220 | US9145354, 267 | BDBM183583)
Affinity DataIC50: 85nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183514(US9145354, 134)
Affinity DataIC50: 85nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183489(US9145354, 95)
Affinity DataIC50: 85nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183544(US9145354, 178)
Affinity DataIC50: 88nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60668(US9145354, 23 | BDBM183408)
Affinity DataIC50: 89nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183405(US9145354, 1)
Affinity DataIC50: 89nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183501(US9145354, 113)
Affinity DataIC50: 93nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183570(US9145354, 212)
Affinity DataIC50: 94nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183596(US9145354, 250)
Affinity DataIC50: 95nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183537(US9145354, 167)
Affinity DataIC50: 98nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183569(US9145354, 210)
Affinity DataIC50: 98nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60668(US9145354, 23 | BDBM183408)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183612(US9145354, 276)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183551(US9145354, 186)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183495(US9145354, 106)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60723(US9145354, 268 | BDBM183602)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183605(US9145354, 263)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183492(US9145354, 101)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183586(US9145354, 238)
Affinity DataIC50: 110nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183503(US9145354, 119)
Affinity DataIC50: 120nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183513(US9145354, 133)
Affinity DataIC50: 120nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183506(US9145354, 126 | US9145354, 127 | US9145354, 125)
Affinity DataIC50: 120nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183486(US9145354, 90)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183542(US9145354, 173)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183619(US9145354, 286)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183415(US9145354, 11)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183611(US9145354, 275)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM60719(US9145354, 265 | BDBM183478)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Astex Therapeutics

US Patent
LigandPNGBDBM183584(US9145354, 235)
Affinity DataIC50: 130nMT: 2°CAssay Description:The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
US Patent

Displayed 1 to 50 (of 231 total ) | Next | Last >>
Jump to: